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Summary box
What is already known about this subject?
 ► Colorectal cancer (CRC) survival is a function of the 
stage of the disease at diagnosis.
 ► Prediagnostic and postdiagnostic lifestyle and di-
etary factors may influence survival.
What are the new findings?
 ► This study evaluates several lifestyle and dietary 
factors in the presence of competing mortality risks.
 ► Prediagnostic vitamin D intake could improve CRC 
survival.
How might it impact on clinical practice in the 
foreseeable future?
 ► Ensuring adequate daily intake of vitamin D could 
become an essential clinical and nutritional goal.
AbSTrACT
background It remains unclear whether or which 
prediagnostic lifestyle and dietary factors influence 
colorectal cancer (CRC) survival following diagnosis. This 
study used competing mortality risks analysis to evaluate 
the association between these factors and CRC survival.
Methods A total of 96 889 cancer- free participants of 
the Norwegian Women and Cancer Study completed the 
study’s baseline questionnaire on lifestyle and dietary 
factors between 1996 and 2004. Of the 1861 women 
who subsequently developed CRC, 550 had CRC as 
the cause of death, while 110 had a non- CRC cause of 
death. We used multiple imputation to handle missing 
data. We performed multivariable competing mortality 
risks analyses to determine the associations between 
prediagnostic lifestyle and dietary factors and CRC 
survival. Cause- specific HRs were estimated by Cox 
regression and subdistribution HRs were estimated by the 
Fine- Gray regression with corresponding 95% CIs.
results Following multivariable adjustment, a 
prediagnostic vitamin D intake of >10 μg/day compared 
with ≤10 μg/day was associated with better CRC survival 
(HR=0.75, 95% CI 0.61 to 0.92). Other prediagnostic 
lifestyle and dietary factors showed no association with 
CRC survival. The corresponding results obtained from 
cause- specific Cox and Fine- Gray regressions were 
similar.
Conclusion Our study shows that prediagnostic vitamin D 
intake could improve CRC survival.
IntroductIon
Colorectal cancer (CRC) is the fourth 
leading cause of cancer- related death world-
wide1 2 and the second leading cause in high- 
income countries.3 CRC is an important 
public health concern in that it imposes a 
considerable medical and economic burden, 
and temporal and demographic projections 
predict that this burden will increase by about 
60% by 2030.1–4 CRC incidence is increasing 
globally,2 4 and the combination of this high 
incidence and improved CRC management 
is giving rise to a relatively large population 
of CRC survivors, especially in countries such 
as Norway, where incidence is still on the rise 
and mortality continues to decrease.1
Primarily, CRC is considered both a 
genetic and lifestyle disease. The relationship 
between CRC incidence and factors like adult- 
attained height, physical activity, obesity, 
socioeconomic status, alcohol consumption, 
smoking status, and certain dietary factors 
has been investigated extensively, with some 
clearly established associations.2 However, 
the relationship between CRC survival and 
these same factors has yet to be expansively 
researched.5 This knowledge gap has been 
attributed to a comparative lack of relevant 
data.6
The primary predictor of CRC survival is 
the stage of the disease at the time of diag-
nosis.2 7 However, there is still variability in 
the survival among people with similar stages 
of CRC and similar access to healthcare,7 
which may be due to variations in lifestyle 
and dietary habits before and/or after CRC 
diagnosis.6–9 For instance, vitamin D status as 















astroenterol: first published as 10.1136/bm





2 Oyeyemi SO, et al. BMJ Open Gastro 2019;6:e000338. doi:10.1136/bmjgast-2019-000338
Open access 
Figure 1 Flowchart of the study sample of colorectal cancer survivors in the Norwegian Women and Cancer Study.
been shown to be related to survival among patients with 
some organ- specific cancers.10 A recent review of the liter-
ature concluded that both prediagnostic and postdiag-
nostic lifestyle factors, including physical activity, obesity, 
and dietary habits, may play a critical role in improving 
CRC survival.8
The Norwegian Women and Cancer (NOWAC) Study 
offers the opportunity to study prediagnostic lifestyle and 
dietary factors and subsequent CRC survival following 
diagnosis. This study used competing mortality risks anal-
ysis to evaluate the association between these factors and 
CRC survival.
Methods
The NOWAC Study is a prospective population- based 
cohort study that was initiated in 1991 and has been 
described in detail elsewhere.11 12 In brief, Norwegian 
women between the ages of 30 and 70 years were randomly 
selected from the Norwegian Central Population Register 
(Statistics Norway) and invited to participate. More than 
172 000 women, recruited at different time periods, gave 
written informed consent and completed a questionnaire 
that collected information on lifestyle factors, health 
status, and dietary habits.
study sample
In this study, we included 101 316 eligible participants 
who completed a baseline questionnaire, which included 
a food frequency questionnaire (FFQ), between 1996 
and 2004. We excluded those who emigrated, died, or 
had prevalent cancer (n=4427) before the start of study 
recruitment. Of the 96 889 remaining participants, 13 
487 developed cancer during follow- up, of whom 1875 
were diagnosed with CRC. Women diagnosed at autopsy 
(n=8), as well as those with unknown cancer stage (n=3) or 
an undocumented cause of death (n=3), were excluded, 
leaving a final analytical sample of 1861 women with a 
CRC diagnosis (figure 1).
Ascertainment of cancer diagnosis in the study sample
The 1861 women included in our study sample had 
primary incident CRC (International Classification of 
Diseases, 10th Revision (ICD-10) codes C18–C20) diag-
nosed between study recruitment and 31 December 2016. 
CRC diagnosis, dates of diagnosis, and cancer stage were 
obtained through record linkage to the Cancer Registry 
of Norway (CRN), which has been acknowledged to be 
more than 98% complete.13 The CRN uses the patholog-
ical tumour, node, and metastasis staging system, which 
is considered the most accurate and reliable staging 
system.14 15
Assessment of emigration, death, and cause of death
Information on dates of emigration and death was 
obtained through record linkage to the Norwegian 
Population Registry, while information on cause of death 
was obtained from the Cause of Death Registry. Primary 
causes of death were then categorised into death due to 
CRC (ICD-10 codes C18–C20), hereafter referred to as 
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referred to as non- CRC death. Follow- up time was defined 
as the period in days between the date of CRC diagnosis 
and the date of emigration, death, or the end of follow- up 
(31 December 2016), whichever occurred first.
Assessment of prediagnostic lifestyle and dietary factors
The choice of prediagnostic lifestyle and dietary factors 
considered in this analysis was based on the literature, 
previous similar studies,6–9 16 and availability in the 
NOWAC Study database. Information on prediagnostic 
physical activity, height, weight, duration of education, 
annual household income, alcohol intake, smoking 
habits, dietary habits, and self- reported medical condi-
tions was extracted from the NOWAC questionnaire.
Physical activity was reported on a 10- point scale, where 
1 was ‘very low’ and 10 was ‘very high’. This is a validated 
scale,17 which implicitly included recreational, occupa-
tional, transportation, and domestic physical activities in 
a global format. We categorised this into 1–2 (least active), 
3–4, 5–6, 7–8, and 9–10 (most active). Height and body 
weight were self- reported and were used to compute the 
body mass index (BMI) as the weight in kilogram divided 
by the square of the height in metre. We categorised BMI 
into underweight (<20.0 kg/m2), normal weight (20.0–
24.9 kg/m2), overweight (25.0–29.9 kg/m2), and obese 
(≥30.0 kg/m2). We used <20.0 kg/m2 as the cut- off point 
for the underweight category because few women had a 
BMI of <18.5 kg/m2. Duration of education was catego-
rised into low (0–9 years), medium (10–12 years), and 
high (>12 years). These categories correspond to primary 
and lower secondary schools, upper secondary school, 
and higher education, respectively. Annual household 
income in Norwegian kroner (NOK) was categorised 
into low (<300 000 NOK), medium (300–600 000 NOK), 
and high (>600 000 NOK). Alcohol intake was catego-
rised as none, ≤3.0 g/day, >3.0–10.0 g/day, and >10.0 g/
day; and smoking status was categorised as never, former, 
or current.
The validated FFQ in the baseline questionnaire 
included foods that are common in Norway.18 We used 
either hypothesis- driven or data- driven percentiles to 
categorise average daily dietary intake into groups. 
Hypothesis- driven cut- offs were based on nutritional 
recommendations and/or knowledge of diet–disease 
associations; while data- driven cut- offs were based on 
the 50th or 75th percentile values of the study sample. 
We combined red meat and processed meat and created 
two categories of consumption: ≤70 and >70 g/day. The 
World Cancer Research Fund/American Institute for 
Cancer Research recommend a red meat intake of not 
more than 50–70 g/day, and little or no processed meat 
intake.19 Fish intake was categorised into ≤130 and >130 
g/day, fruit and vegetable intake into ≤300 and >300 g/
day, and vitamin D intake into ≤10.0 and >10 µg/day, as 
10 µg/day is the Nordic nutrition recommendation.20 
Participants were categorised as having or not having 
(yes or no) the prediagnostic comorbidities of diabetes 
mellitus and cardiovascular disease (CVD). CVD included 
self- reported medical conditions such as hypertension, 
angina pectoris, infarction, and stroke.
statistical methods
Competing mortality risks analysis
CRC survivors are also at risk of dying from causes other 
than CRC. Indeed, CRC is predominantly a disease of 
the middle- aged and the elderly, bearing in mind that 
mortality increases exponentially with age after the age 
of 35 years, especially in high- income countries.21 Thus, 
we chose to use competing risks analysis.
We extended the standard Cox proportional hazard 
model, normally used when there are no competing 
events, to model cause- specific hazards as proposed by 
Prentice et al.22 We applied the model to cause- specific 
hazards of (1) CRC death and (2) non- CRC death, 
respectively. In each model, we censored the competing 
event while estimating the effects of lifestyle and dietary 
factors on the risk of death. This is the method of choice 
when focusing on epidemiological questions of aetiology 
(such as factors associated with CRC death), rather than 
the probability of CRC death, both in the presence of 
competing risks.23–26
In addition, we used the subdistribution hazard model 
approach proposed by Fine and Gray.27 This is because 
of the inherent hypothetical setting of a cause- specific 
hazard model in which the ‘competing event is removed’ 
(censored). The estimations from the Fine and Gray 
approach is in the ‘presence of competing events’, 
thereby removing the hypothetical setting by modelling 
hazards on the basis of the cumulative incidence func-
tion.23 We used these two statistical methods to gain 
complete understanding of the effects of lifestyle and 
dietary factors on competing risk endpoints, as recom-
mended by Latouche et al.28 We used these methods to 
estimate HRs and subdistribution HRs (SHRs), with 95% 
CIs for the associations between lifestyle and dietary 
factors, and CRC death and non- CRC death, respectively. 
CRC death was the event of interest, while non- CRC 
death was the competing event.
We used Schoenfeld residuals to check the propor-
tional hazards assumption in the two approaches and 
with the two competing events, respectively. In order 
to keep the proportional hazards assumption, we had 
to run all models stratified by CRC stage. We used the 
Breslow approximation method to handle tied failures. 
We adjusted for prediagnostic follow- up duration, which 
is the period between the date of NOWAC recruitment 
and CRC diagnosis, in all models. We tested for linear 
trend by using variables originally in continuous scale as 
continuous variables in the model. We assessed collin-
earity between the prediagnostic variables fish intake and 
vitamin D intake, and predefined interactions between 
physical activity and BMI, physical activity and vitamin 
D intake, duration of education and annual household 
income, and fish intake and vitamin D intake, respec-
tively. The final prediagnostic variables included in all 
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BMI; duration of education; annual household income; 
alcohol intake; smoking status; red and processed meat 
intake, fish intake, and fruit and vegetable intake; and 
vitamin D intake. We also included diabetes mellitus 
status and CVD status.
Multiple imputation
We used multiple imputation to handle missing data 
under the assumption that data were missing at random.29 
We replaced missing values by computed estimates of 
50 replicate datasets from multiple imputations using 
chained equations. We created 50 replicates to minimise 
variability30 and used Rubin’s rules to coalesce the values 
from the 50 imputed replicates to estimate HRs and SHRs 
with corresponding 95% CIs.31 32
In order to rule out the effects of latent disease condi-
tions, we conducted sensitivity analyses excluding those 
who died less than 1 year after recruitment and those 
who died less than 1 year after CRC diagnosis, respec-
tively. We also assessed reverse causation by excluding 
women who had CRC diagnosis less than 1 year after 
recruitment. To minimise the impact of changes in life-
style and dietary habits during follow- up, we conducted 
further analysis restricted to women who received a CRC 
diagnosis within 10 years of recruitment. Finally, we ran a 
sensitivity analysis in which we did not include CRC cases 
diagnosed after 31 December 2014 to allow for a longer 
follow- up time.
Analyses were performed using STATA V.15.0 and R 
V.3.5.3 (R Foundation for Statistical Computing 2019). 
All statistical analyses were two- sided, and p values were 
considered statistically significant at a level of <0.05.
results
Of the 1861 women with CRC in our study sample, 65% 
(1201/1861) were alive, and 35% (660/1861) had died 
by the end of follow- up (31 December 2016). Of these 
deaths, 83% (550/660) were CRC deaths and 17% 
(110/660) were non- CRC deaths. The mean age was 67.6 
years at CRC death and 75.9 years at non- CRC death. The 
average duration of follow- up was 5 years. This was lower 
among CRC deaths (2.1 years) compared with non- CRC 
deaths (5.3 years) (table 1). Other cancer types (41.8%) 
and CVD (30.0%) were the most common causes of non- 
CRC death.
Most CRC survivors (92%, 1107/1201) who were alive at 
the end of follow- up had been diagnosed with early- stage 
CRC (localised or regional spread), whereas more than 
half (60%, 330/550) of CRC deaths had been diagnosed 
with advanced- stage CRC (remote metastases). Non- 
CRC death (88%, 97/110) was more common in those 
who were diagnosed with early- stage CRC (localised or 
regional spread). Few CRC survivors reported comorbid-
ities at recruitment, with less than 3% (48/1861) having 
diabetes mellitus and less than 20% (358/1861) having 
CVD (table 1).
The prediagnostic variables with the highest proportion 
of missing values were physical activity (13.4%), annual 
household income (9.1%), alcohol intake (7.7%), and 
duration of education (7.5%) (online supplementary 
table 1). After multiple imputation, there was no substan-
tial change in the characteristic features of the study 
sample between the complete- case and the imputed data-
sets (online supplementary table 2).
competing risks mortality analyses
We present the multivariable competing risk regressions 
of the imputed datasets in table 2, with the estimated HRs, 
SHRs, and the corresponding 95% CIs. We observed a 
5% increase in the cause- specific hazard of CRC death 
(HR=1.05, 95% CI 1.03 to 1.06) for each 1- year increase 
in age at diagnosis; the corresponding increase for non- 
CRC death was 12% (HR=1.12, 95% CI 1.08 to 1.16). Simi-
larly, each 1- year increase in age at diagnosis raised the 
cumulative incidence of CRC death by 4% (SHR=1.04, 
95% CI 1.03 to 1.06) and that of non- CRC death by 9% 
(SHR=1.09, 95% CI 1.06 to 1.13) (table 2).
Participants with a prediagnostic physical activity level of 
1–2 (compared with 5–6) had a small and non- significant 
lower cause- specific hazard of CRC death (HR=0.95, 95% 
CI 0.62 to 1.44), whereas the corresponding cause- specific 
hazard of non- CRC death was more than 100% higher 
(HR=2.14, 95% CI 1.05 to 4.37). The cause- specific HRs 
for the two competing events went in opposite directions. 
This same phenomenon was also demonstrated by predi-
agnostic CVD (table 2). Similar results were observed in 
corresponding cumulative incidence estimates. Prediag-
nostic current smoking was important only in non- CRC 
deaths (HR=1.98, 95% CI 1.21 to 3.23).
Our results revealed that participants with a prediag-
nostic vitamin D intake of >10 µg/day, compared with 
those with an intake of ≤10.0 µg/day, had a 25% lower 
cause- specific hazard of CRC death (HR=0.75, 95% CI 
0.61 to 0.92, p trend=0.001) and a 23% lower cumula-
tive incidence of CRC death (SHR=0.77, 95% CI 0.62 to 
0.96, p trend=0.001). In both cause- specific and cumu-
lative incidence approaches, our data did not show any 
association between prediagnostic BMI and CRC death. 
Similarly, no association was observed between other 
prediagnostic variables, such as duration of education, 
annual household income, alcohol intake, fish intake, 
and diabetes mellitus status, and CRC death.
Sensitivity analyses excluding those who died less than 
1 year after recruitment and another excluding those 
who died less than 1 year after diagnosis did not change 
our findings in either of the competing risks approaches. 
When women diagnosed with CRC less than 1 year after 
recruitment were excluded to test for reverse causation, 
the analysis yielded similar estimates. We also conducted 
analyses that considered only incident CRC diagnosed 
before 31 December 2014, in order to allow for more 
follow- up time. However, for both of the aforementioned 
analyses, the associations and estimates of other variables 
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Table 1 Prediagnostic demographic, lifestyle, and dietary characteristics of the study sample at recruitment and during 
follow- up: the Norwegian Women and Cancer Study (N=1861)
Characteristics
Categories or 
parameters Numbers (%) Alive
Died of
CRC
Died of other 
causes
Total cohort, n (%) 1861 1201 (64.5) 550 (29.6) 110 (5.9)




























Mean prediagnostic follow- up 
duration
Years (SD) 10.5 (5.4) 11.3 (5.3) 8.8 (5.2) 9.3 (4.7)
Mean postdiagnosis survival 
duration
Years (SD) 5.0 (4.7) 6.4 (5.0) 2.1 (2.3) 5.3 (4.3)
CRC stage, n (%) Localised 452 (24.3) 377 (31.4) 32 (5.8) 43 (39.1)
Regional spread 972 (52.2) 730 (60.8) 188 (34.2) 54 (49.1)
Remote metastases 437 (23.5) 94 (7.8) 330 (60.0) 13 (11.8)
Physical activity 1–2 (least active) 83 (5.2) 46 (4.4) 26 (5.4) 11 (12.4)
3–4 366 (22.7) 236 (22.7) 112 (23.3) 18 (20.2)
5–6 687 (42.6) 458 (43.9) 198 (41.3) 31 (34.8)
7–8 385 (23.9) 248 (23.8) 116 (24.2) 21 (23.6)
9–10 (most active) 90 (5.6) 54 (5.2) 28 (5.8) 8 (9.0)
Body mass index, n (%) Underweight (<20.0) 100 (5.5) 52 (4.4) 41 (7.7) 7 (6.6)
Normal (20.0–24.9) 883 (48.7) 583 (49.6) 253 (47.6) 47 (44.4)
Overweight (25.0–29.9) 640 (35.3) 417 (35.5) 188 (35.3) 35 (3.0)
Obese ≥30.0 190 (10.5) 123 (10.5) 50 (9.4) 17 (16.0)
Duration of education <10 years 658 (38.2) 413 (36.9) 197 (39.2) 48 (48.0)
10–12 years 583 (33.9) 383 (34.2) 171 (34.1) 29 (29.0)
>12 years 480 (27.9) 323 (28.9) 134 (26.7) 23 (23.0)
Annual household income <300 000 NOK 857 (50.7) 515 (46.7) 274 (55.8) 68 (70.1)
301 000–600 000 NOK 688 (40.6) 483 (43.7) 178 (36.3) 27 (27.8)
>600 000 NOK 147 (8.7) 106 (9.6) 39 (7.9) 2 (2.1)
Alcohol intake (g/day) None 472 (27.5) 315 (28.3) 119 (23.5) 38 (38.4)
≤3.0 g 720 (41.9) 447 (40.2) 231 (45.5) 42 (42.4)
>3.0–10.0 g 395 (23.0) 259 (23.3) 121 (23.9) 15 (15.2)
>10.0 g 131 (7.6) 91 (8.2) 36 (7.1) 4 (4.0)
Smoking status Never smoker 627 (34.2) 410 (34.7) 173 (31.9) 44 (40.7)
Former smoker 666 (36.4) 437 (37.0) 202 (37.3) 27 (25.0)
Current smoker 538 (29.4) 334 (28.3) 167 (30.8) 37 (34.3)
Red and processed meat intake 
combined (g/day)
≤70.0 g 1523 (81.8) 986 (82.1) 444 (80.7) 93 (84.6)
>70.0 g 338 (18.2) 215 (17.9) 106 (19.3) 17 (15.4)
Fish intake (g/day) ≤130 g 1364 (73.3) 890 (74.1) 401 (72.9) 73 (66.4)
>130 g 497 (26.7) 311 (25.9) 149 (27.1) 37 (33.6)
Fruit and vegetable intake (g/day) ≤300 g 1002 (53.8) 629 (52.4) 296 (53.8) 77 (70.0)
>300 g 859 (46.2) 572 (47.6) 254 (46.2) 33 (30.0)
Vitamin D intake (μg/day) ≤10.0 µg 1340 (72.0) 851 (70.9) 411 (74.7) 78 (70.9)
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parameters Numbers (%) Alive
Died of
CRC
Died of other 
causes
Diabetes mellitus, n (%) No 1813 (97.4) 1175 (97.8) 532 (96.7) 106 (96.4)
Yes 48 (2.6) 26 (2.2) 18 (3.3) 4 (3.6)
Cardiovascular diseases No 1503 (80.8) 981 (81.7) 450 (81.8) 72 (65.4)
Yes 358 (19.2) 220 (18.3) 100 (18.2) 38 (34.6)
CRC, colorectal cancer; NOK, Norwegian kroner; SD, standard deviation.
Table 1 Continued
interaction terms tested were statistically significant in 
any of the outcomes investigated.
The Arctic Circle divides Norway into approximately 
two equal parts. As a complementary analysis for vitamin 
D status through sunlight exposure, we conducted a 
parallel multivariable- adjusted analysis in which we 
compared CRC survival in participants living above and 
below the Arctic Circle. Those living above the Arctic 
Circle (North Norway) were at a non- significant higher 
risk of CRC death (HR=1.10, 95% CI 0.90 to 1.35) 
compared with the rest of Norway.
dIscussIon
We found a lower risk of CRC death associated with a 
prediagnostic vitamin D intake of >10 µg/day, with 
evidence of a monotonic relationship between the intake 
and the risk of CRC death, using competing mortality 
risks approach and chained multiple imputation. The 
results were consistent with those of the complete- case 
analysis. The lower risk of death associated with prediag-
nostic fruit and vegetable intake and the increased risk 
of death associated with prediagnostic current smoking 
were both more pronounced and statistically significant 
only for non- CRC death. The apparent reduction in the 
risk of CRC death in those with CVD that we observed 
could be explained via the effects of the variable on the 
competing cause of death (non- CRC death). The same 
phenomenon was also seen among participants with the 
lowest prediagnostic physical activity level. We did not 
find any evidence of association between prediagnostic 
BMI, annual household income, alcohol intake, red and 
processed meat intake, fish intake, and diabetes mellitus 
status, and CRC survival.
Our results regarding prediagnostic vitamin D intake 
and decreased risk of CRC death are consistent with 
findings from the European Prospective Investiga-
tion into Cancer and Nutrition (EPIC) study, in which 
prediagnostic vitamin D level was estimated directly by 
measuring circulating 25- hydroxyvitamin D (25(OH)
D) levels in the blood. The EPIC study reported a 31% 
lowered risk of death in those within the highest quin-
tile compared with the lowest quintile of 25(OH)D 
(adjusted HR=0.69, 95% CI 0.50 to 0.93).33 Some other 
studies found similar results,34–36 while others found 
no association.10 37 However, a recent updated system-
atic review and meta- analysis compared the highest and 
lowest categories of blood 25(OH)D and concluded that 
sufficient vitamin D offers better survival in patients with 
CRC (pooled HR=0.67, 95% CI 0.57 to 0.78).38 Physio-
logically, the most active molecular form of vitamin D, 
1α,25- dihydroxyvitamin D3, has the capacity to inhibit 
cell proliferation, angiogenesis, and metastatic potential. 
It also induces differentiation and apoptosis in the cells 
of organs such as the large intestine.39 40
Few studies have investigated the association between 
prediagnostic fruit and vegetable intake and CRC- 
specific mortality, but the comparable studies that do 
exist found results similar to ours. A study using data 
from the Cancer Prevention Study- II (CPS- II) Nutrition 
Cohort did not find any association.41 That study used 
prediagnostic dietary patterns, characterised mainly by a 
high intake of fruits and vegetables (termed the prudent 
dietary pattern),41 and the American Cancer Society 
(ACS) Guidelines on Nutrition and Physical Activity for 
Cancer Prevention42 to score participants.41 43 The ACS 
score is based on the intake of at least five servings per 
day of a variety of mainly fruits and vegetables. Neither 
the prudent dietary pattern nor the ACS score- based 
dietary pattern was associated with CRC- specific mortality 
(HR=0.85, 95% CI 0.64 to 1.13, and HR=0.74, 95% CI 
0.54 to 1.03, respectively).41 In contrast to CRC inci-
dence, we did not find an association between prediag-
nostic combined red and processed meat intake and CRC 
survival. This is consistent with results from the EPIC 
study44 and the Western dietary pattern described in the 
CPS- II Nutrition Cohort study, which was characterised 
by a high intake of red and processed meats.41 A recent, 
large, pooled analysis of CRC survivors also did not find 
any association between the highest prediagnostic red or 
processed meat intake and CRC survival when compared 
with the lowest intake.45 However, consistently high 
prediagnosis and postdiagnosis red and processed meat 
intake has been associated with an increased risk of CRC 
death (HR=1.79, 95% CI 1.11 to 2.89).46 Similar to our 
findings, most previous studies found no evidence of an 
association between prediagnostic alcohol intake and 
CRC death.16 47 48 Interestingly, some studies posited that 
prediagnostic wine intake may favour CRC survival.48–50
Smoking is a well- known risk factor for many cancers, 
including CRC,51–53 and it has also been associated with 
overall mortality.54–56 Our study did not find any associ-
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survival, although we observed an almost 100% increased 
risk of non- CRC death among participants who were 
current smokers prior to CRC diagnosis compared 
with never smokers. The lack of an association between 
prediagnostic smoking status and CRC death, and the 
presence of an association between this variable and non- 
CRC death could be attributed to the fact that smoking 
increases the incidence of several diseases and thus could 
indirectly increase the risk of non- CRC death. Neverthe-
less, a study using data from the CPS- II Nutrition Cohort 
found an association with prediagnostic current smoking 
but not former smoking.55 However, our findings are in 
agreement with the results of a recent meta- analysis of 
14 prospective cohort studies on prediagnostic smoking 
status and CRC survival.56 The authors found no associ-
ation between prediagnostic former smoking (pooled 
HR=1.00, 95% CI 0.91 to 1.09) or current smoking 
(pooled HR=1.15, 95% CI 0.95 to 1.41) and CRC survival, 
but they did find an association with overall survival.56 
While higher education has been noted as a predictor of 
healthy lifestyle57 58 and is inversely related to CRC inci-
dence in the NOWAC cohort,59 we found no association 
between duration of education and CRC survival.
The cause- specific HRs for the two competing events 
(CRC death and non- CRC death) in our study appar-
ently went in opposite directions in the least physically 
active and those with CVD, which is consistent with the 
SHRs of cumulative incidence. This ‘opposite directions’ 
phenomenon was previously reported by Latouche et al28 
and Austin et al.60 This demonstrates that a variable could 
reduce the occurrence of the event of interest (CRC 
death) by increasing the occurrence of the competing 
event (non- CRC death). However, the variable does not 
necessarily affect the causal mechanism that produces 
the event of interest (CRC death). Nonetheless, patients 
with comorbidities such as diabetes mellitus and CVD are 
known to have lower odds of receiving treatment with a 
curative intent and to be at a greater risk of death than 
those without any comorbidity.61
Competing risks imply that a subject can experience 
a competing event that prevents the occurrence of the 
outcome of interest.60 The two approaches we used for 
handling the competing mortality risk data rendered 
similar results. These approaches could give different 
results because the composition of the risk sets in the 
two approaches differs,24 and especially if the competing 
event occurs early in follow- up and is frequent.24 62 63 In 
our study, the corresponding HRs and SHRs were similar 
numerically because the competing event (non- CRC 
death) was relatively infrequent.
The interpretation of these findings is subject to some 
limitations. One main limitation is that the prediagnostic 
lifestyle and dietary information we used was collected 
at recruitment, and only once before CRC diagnosis. 
Lifestyle and dietary habits could have changed before 
or after diagnosis and may have affected CRC survival. A 
repeat measurement of prediagnostic lifestyle and dietary 
factors could mitigate the impact of such changes. To 
minimise the impact of such changes during follow- up, 
we conducted sensitivity analyses restricted to CRC diag-
nosed within 10 years of recruitment. Even though we 
observed some changes, the estimates and associations 
(or lack thereof) remained essentially the same. None-
theless, in a previous study of the NOWAC cohort, where 
prediagnosis and postdiagnosis assessments in CRC survi-
vors were made, results showed only substantial changes 
in vegetable intake, BMI, and smoking status.64 Notably, 
over 50% of the participants quit smoking after their 
CRC diagnosis, compared with 20% in the cancer- free 
women.64 This may create a healthy ripple effect, leading 
to fewer comorbidities and an improved quality of life 
among CRC survivors. Second, we do not have access to 
the details of CRC treatment, and thus we were unable 
to evaluate treatment as an outcome modifier. CRC 
stage at diagnosis correlates with treatment options, but 
this will not completely assuage the limitation.65 Third, 
measurement errors and misclassification of variables 
are inherent in self- reported assessments of lifestyle and 
dietary habits (including overestimation or underesti-
mation of social desirable behaviours), and unmeasured 
potential confounding factors may have influenced our 
estimates. For instance, vitamin D intake estimation was 
based on dietary intake and cod liver oil supplement 
intake; thus, intake of other vitamin D supplements 
or outdoor exposure to the solar radiation may have 
confounded these estimates. Moreover, we did not have 
data on family history of CRC and its precursors (such 
as colonic adenomas). Fourth, the relatively small size of 
some of the subgroups in our sample (for instance, in 
the most physically active participants) may have limited 
our analysis from detecting valid associations. Finally, we 
obtained information on cause of death from the Cause 
of Death Registry, and misclassification of the primary 
cause of death is a possibility we cannot completely rule 
out.66
The strengths of this study include its prospective 
nature, the large sample size, prediagnostic information 
on several important lifestyle and dietary factors, and the 
high quality of data in the CRN that was used to identify 
CRC cases. The use of chained multiple imputation to 
handle missing data maximises the number of CRC survi-
vors in the analyses. Most lifestyle and dietary factors in 
the NOWAC Study have been validated previously.17 18 67 68
conclusIon
While we found no evidence of an association between 
CRC survival and prediagnostic physical activity, BMI, 
education, alcohol, or red and processed meat intake, 
our study showed that prediagnostic vitamin D intake 
could improve CRC survival. However, prediagnostic 
repeat measurements and/or postdiagnostic measure-
ments would be desirable to draw a firmer conclusion.
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